Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 07 February, 2020

Citadel Group

Form 8.3 - Allergan plc

RNS Number : 3500C
Citadel Group
07 February 2020
 
























 

Ap 19

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.         KEY INFORMATION


























Name of person dealing (Note 1)

Citadel Group

Company dealt in

ALLERGAN PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common Stock ISIN IE00BY9D5467

Date of dealing

06 February, 2020

























2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security

                    dealt in (Note 3)









Long

Short

Common Stock  ISIN  IE00BY9D5467

Number        (%)

Number      (%)

(1) Relevant securities

701,899 (0.21%)

0 (0.00%)

(2) Derivatives (other than options)

3,809,048 (1.16%)

2,123 (0.00%)

(3) Options and agreements to purchase/sell

0 (0.00%)

200,000 (0.06%)

Total

4,510,947(1.37%)

202,123 (0.06%)



























 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

























Long

Short


Number        (%)

Number      (%)

(1) Relevant securities



(2) Derivatives (other than options)



(3) Options and agreements to purchase/sell



Total































Ap 20






























1.         DEALINGS (Note 4)

 

(a)        Purchases and sales





























Purchase/sale

Common Stock ISIN IE00BY9D5467

Number of securities

Price per unit (Note 5)

Purchase

400

191.95  USD

Purchase

300

192.02  USD

Purchase

250

192.04  USD

Purchase

150

192.05  USD

Purchase

100

192.1  USD

Purchase

105

192.18  USD

Purchase

200

192.26  USD

Purchase

100

192.29  USD

Purchase

300

192.3  USD

Purchase

300

192.31  USD

Purchase

100

192.32  USD

Purchase

251

192.35  USD

Purchase

100

192.38  USD

Purchase

200

192.4  USD

Purchase

200

192.41  USD

Purchase

300

192.42  USD

Purchase

20

192.43  USD

Purchase

257

192.46  USD

Purchase

100

192.47  USD

Purchase

800

192.49  USD

Purchase

500

192.5  USD

Purchase

281

192.51  USD

Purchase

200

192.54  USD

Purchase

400

192.55  USD

Purchase

300

192.58  USD

Purchase

101

192.59  USD

Purchase

500

192.6  USD

Purchase

121

192.61  USD

Purchase

1,240

192.62  USD

Purchase

66

192.65  USD

Purchase

102

192.67  USD

Purchase

102

192.68  USD

Purchase

367

192.69  USD

Purchase

421

192.7  USD

Purchase

305

192.71  USD

Purchase

100

192.72  USD

Purchase

400

192.73  USD

Purchase

487

192.74  USD

Purchase

724

192.75  USD

Purchase

100

192.76  USD

Purchase

360

192.77  USD

Purchase

200

192.78  USD

Purchase

200

192.79  USD

Purchase

164

192.81  USD

Purchase

301

192.86  USD

Purchase

10

192.87  USD

Purchase

403

192.88  USD

Purchase

100

193  USD

Sale

-100

191.98  USD

Sale

-100

192  USD

Sale

-150

192.02  USD

Sale

-200

192.09  USD

Sale

-100

192.18  USD

Sale

-5

192.19  USD

Sale

-5

192.2  USD

Sale

-200

192.21  USD

Sale

-100

192.23  USD

Sale

-14

192.28  USD

Sale

-243

192.31  USD

Sale

-251

192.32  USD

Sale

-162

192.36  USD

Sale

-193

192.37  USD

Sale

-100

192.39  USD

Sale

-890

192.4  USD

Sale

-200

192.41  USD

Sale

-408

192.42  USD

Sale

-600

192.43  USD

Sale

-5

192.45  USD

Sale

-477

192.46  USD

Sale

-200

192.47  USD

Sale

-852

192.48  USD

Sale

-690

192.49  USD

Sale

-86

192.51  USD

Sale

-100

192.52  USD

Sale

-200

192.53  USD

Sale

-78

192.54  USD

Sale

-200

192.56  USD

Sale

-150

192.57  USD

Sale

-902

192.58  USD

Sale

-300

192.59  USD

Sale

-107

192.61  USD

Sale

-200

192.63  USD

Sale

-145

192.68  USD

Sale

-312

192.69  USD

Sale

-200

192.7  USD

Sale

-147

192.72  USD

Sale

-523

192.73  USD

Sale

-100

192.74  USD

Sale

-343

192.75  USD

Sale

-129

192.76  USD

Sale

-5

192.765  USD

Sale

-361

192.77  USD

Sale

-735

192.78  USD

Sale

-157

192.8  USD

Sale

-60

192.82  USD

Sale

-100

192.83  USD

Sale

-100

192.84  USD

Sale

-1,679

192.88  USD

Sale

-100

192.99  USD

Sale

-349

193.02  USD

Sale

-100

193.03  USD

Sale

-355

193.04  USD

Sale

-100

193.06  USD

Sale

-100

193.07  USD

Sale

-130

193.08  USD

Sale

-15

193.1  USD

Sale

-30

193.11  USD





















(b)        Derivatives transactions (other than options transactions)























Product name,

e.g. CFD

 ISIN

Nature of transaction

(Note 6)

 

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

























(c)        Options transactions in respect of existing relevant securities

 

(i)         Writing, selling, purchasing or varying


















Product name, e.g. call option

Writing, selling, purchasing,

varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type,

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(Note 5)



























(ii)        Exercising
























Product name,

e.g. call option

Number of securities

Exercise price per unit

(Note 5)






























(d)        Other dealings (including transactions in respect of new securities) (Note 4)




























Nature of transaction

(Note 8)

      Details

      Price per unit

      (if applicable) (Note 5)







 



















Ap 21

















2.         OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 
















Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated

None














Is a Supplemental Form 8 attached? (Note 9)


YES

















 Date of disclosure:

07 February, 2020

 Contact name:

Katie Bonds

 Telephone number:

020 7645 9700

If a connected EFM, name of offeree/offeror with which connected

n/a

If a connected EFM, state nature of connection (Note 10)

n/a





 








Ap23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS (Note 1)











Product name,

e.g. call option

Written, or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Put Option

Purchased

-200,000

160 USD

American

2/21/2020












Notes

 

1.          Where there are open option positions or open derivative positions (except for CFDs),  full details should be given. Full details of any existing agreements to urchase or to sell must also be given on this form.

 

2.          For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.








 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEBBGDDRGGDGGR

a d v e r t i s e m e n t